Delivering the right drug to the right patient at the right time

The Pharmacogenomics & Patient Stratification Stage focuses on how pharmacogenomics, polygenic risk scores and multi-omics are enabling personalised prescribing, earlier intervention and precision prevention across healthcare 
Loading
11:30
  1. Pharmacogenomics in Healthcare
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Sir Mark Caulfield
    Sir Mark Caulfield, Professor of Clinical Pharmacology, Queen Mary University of London
12:00
  1. A National Approach to Pharmacogenomics: Developments in Wales
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Sophie Harding
    Sophie Harding, Pharmacogenomics Lead, All Wales Medical Genomics Service
12:30
  1. From Evidence to Infrastructure: Building Pharmacogenomics at National Scale — The Scottish Perspective
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Sandosh Padmanabhan
    Sandosh Padmanabhan, Chair of Pharmacogenomics, University of Glasgow
13:00
  1. Lunch & Networking Break
    Pharmacogenomics & Patient Stratification Stage
    90 mins
14:30
  1. From Risk Prediction to Precision Prevention
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Michael Cook
    Michael Cook, Chief Science Officer, Our Future Health
15:30
  1. From Pilot to Implementation: Bupa’s Use of Genomics for Personalised, Preventive Care
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Rebecca Rohrer
    Rebecca Rohrer, Clinical Innovation and Genomics Director, Bupa
16:00
  1. Networking Break
    Pharmacogenomics & Patient Stratification Stage
    30 mins
16:30
  1. Beyond Single-Gene Testing: Using Polygenic Risk to Guide Precision Treatment
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Michael Inouye
    Michael Inouye, Professor of Systems Genomics & Population Health, University of Cambridge
17:00
  1. Pharmacogenomics in Psychosis: From Genetic Insight to Better Treatment
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Elvira Bramon
    Elvira Bramon, Hon. Consultant Psychiatrist, North London NHS Foundation Trust
17:30
  1. Genotype-Guided Antiplatelet Therapy in Acute Ischemic Stroke
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Anthony Pereira
    Anthony Pereira, Consultant & Hon. Reader in Neurology, St George's Hospital
11:30
  1. One Test, Many Decisions: The Value of Pre-emptive Pharmacogenomics
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Anke-Hilse Maitland-van der Zee
    Anke-Hilse Maitland-van der Zee, Head of Department of Genetics and Professor of Personalised Medicine, University Medical Centre Groningen
12:00
  1. Finding The Right Participants For The Right Research
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Cosima Gretton
    Cosima Gretton, Chief Product Officer, Our Future Health
12:30
  1. Could Polygenic Risk Scores Transform Preventive Health in Wales?
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Meng Khaw
    Meng Khaw, National Director, Health Protection and Screening Services, Public Health Wales
13:00
  1. Lunch & Networking Break
    Pharmacogenomics & Patient Stratification Stage
    70 mins
14:10
  1. From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Ranjit Manchanda
    Ranjit Manchanda, Professor of Gynaecological Oncology, Queen Mary University of London
14:40
  1. The Genomics England Adult Population Programme
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Katie Snape
    Katie Snape, Principal Clinician - Population Health, Genomics England
15:10
  1. Beyond Polygenic Risk Scores: Integrating Genetics and Multi-Omic Data for Personalised Risk Stratification and Earlier Screening
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Emanuele Di Angelantonio
    Emanuele Di Angelantonio, Deputy-Director of the Cardiovascular Epidemiology Unit, University of Cambridge
15:40
  1. Networking Break
    Pharmacogenomics & Patient Stratification Stage
    30 mins
16:10
  1. Critical Appraisal of Polygenic Risk Scores and Circulating Proteins for Screening, Risk Stratification and Individual Risk Prediction
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Aroon Hingorani
    Aroon Hingorani, Professor of Genetic Epidemiology, University College London
16:40
  1. Rethinking Monogenic DIsease in the Era of Population Genomics
    Pharmacogenomics & Patient Stratification Stage
    30 mins
    Speaker(s)
    Speaker image for Arianna Tucci
    Arianna Tucci, Clinical Reader in Genomic Medicine, Queen Mary University of London